Stockreport

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

Nuvectis Pharma, Inc.  (NVCT) 
PDF FORT LEE, NJ, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovati [Read more]